FcγRIIa polymorphism in systemic lupus erythematosus

Annals of the Rheumatic Diseases

Volumn 56, Issue 12, 1997, Pages 744-746

  Smyth, L J C ^a   Snowden, N ^b   Carthy, D ^a   Papasteriades, C ^c   Hajeer, A ^a   Ollier, W E R ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b HOPE HOSPITAL   (United Kingdom)

^c EVANGELISMOS HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

FC RECEPTOR;

ALLELE; ARTICLE; DISEASE PREDISPOSITION; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; GREECE; HUMAN; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; UNITED KINGDOM;

EID: 0031414402     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.56.12.744     Document Type: Article

References (13)

1. Kimberly RP, Salmon JE, Edberg JC. Receptors for IgG: Molecular diversity and implications for disease. Arthritis Rheum 1995;38:306-14.
2. Parren PWH, Warmerdam PAM, Boeije LCM., Arts J, Westerdaal NAC, Vlug A, et al. On the interaction of IgG subclasses with the low affinity FcγRIIa (CD32) on human monocytes, neutrophils and platelets. J Clin Invest 1992;90:1537-46.
3. Clark MR, Stuart SG, Kimberly RP, Ory PA, Goldstein IM. A single amino acid distinguishes the HR from the LR form of FcgRII on human monocytes. Eur J Immunol 1991;21: 1911-16.
4. Clark MR, Clarkson SB, Ory PA, Stollman N, Goldstein CM. Molecular basis for a polymorphism involving FcγRII on human monocytes. J Immunol 1989;143:1731-4.
5. Warmerdam PAM, van der Winkel JGJ, Gosselin EJ, Capel PJA. Molecular basis for a polymorphism of FcγRIIa (CD32). J Exp Med 1990;172:19-25.
6. Van de Winkel JGJ, Capel PJA. Human IgG Fc receptor heterogeneity: molecular aspects and clinical implications. Immunol Today 1993;14:215-21.
7. Bredius RGM, Derkx BHF, Fijen CAP, de Wit TPM, de Haas M, Weening RS, et al FcγRIIa (CD32) polymorphism in fulminant meningococcal septic shock in children. J Infect Dis 1994;170:848-53.
8. Salmon JE, Millard S, Schacter LA, Arnett FC, Ginzler EM, Gourley MF, et al. FcγRIIa alleles are heritable risk factors for lupus nephritis in African Americans. J Clin Invest 1996;97:1348-54.
9. Duits AJ, Bootsma H, Derksen RHWM, Spronk PE, Kater L, Kallenberg CGM, et al. Skewed distribution of IgG Fc receptor IIa (CD32) polymorphism is associated with renal disease in systemic lupus erythematosus patients. Arthritis Rheum 1995;38:1832-6.
10. Botto M, Theodoridis E, Thompson EM, Beynon HLC, Briggs D, Isenberg DA, et al. FcγRIIa polymorphism in SLE: no association with disease. Clin Exp Immunol 1996; 104:264-8.
11. Ollier WER, MacGregor A. Genetic epidemiology of rheumatoid disease. Br Med Bull 1995;51:267-85.
12. Schur PH, Monroe M, Rothfield N. The IgG subclass of antinuclear and anti-nucleic acid antibodies. Arthritis Rheum 1972;15:174-82.
13. Wisnieski JJ, Jones SM. Comparison of autoantibodies to the collagen like region of C1q in hypocomplementaemic urticarial vasculitis syndrome and SLE. J Immunol 1992; 148:1396-403.